The Quiet Consolidation Reshaping Eye Care
Across suburban strip malls and mid-size city medical districts, a familiar pattern is playing out: independent optometry practices and regional eye care chains are selling to MyEyeDr, the Virginia-based managed vision care company backed by private equity. The deals rarely make headlines. No press conferences, no splashy announcements. An optometrist retires, a regional group accepts a buyout offer, and within months the signage changes. The process is quiet by design.
MyEyeDr has been executing this playbook for years, growing from a small regional operator into a network spanning hundreds of locations across the United States. The company’s expansion strategy centers on absorbing established local practices rather than building from scratch – acquiring patient rosters, trained staff, and community trust that would take a new location years to develop. For the sellers, the calculation is often straightforward: a liquidity event that rewards years of work, combined with the operational support that comes with belonging to a larger system.
Why Independent Practices Are Saying Yes
Running an independent optometry practice has grown significantly more complicated over the past decade. Insurance reimbursement negotiations, electronic health records compliance, supply chain management for frames and lenses, and the cost of modern diagnostic equipment all create pressure that solo practitioners or small regional groups are increasingly ill-equipped to absorb alone. When a MyEyeDr representative arrives with a purchase offer, many owners are not being caught off guard – they have been quietly preparing for this conversation.
The financial structure of these deals typically involves the acquiring company paying a multiple of the practice’s earnings, sometimes retaining the original optometrist as an employed provider under a multi-year agreement. This arrangement lets the selling doctor continue practicing without carrying the weight of business ownership. From a pure economics standpoint, the offer often outpaces what a private buyer or associate buyout would generate, particularly in markets where finding a qualified successor willing to take on practice debt is increasingly difficult.
The Private Equity Engine Behind the Growth
MyEyeDr’s acquisition appetite does not exist in isolation. The company operates under the ownership of Goldman Sachs Asset Management, which acquired a majority stake in the business in 2019. Private equity ownership changes the math entirely: the business is no longer optimizing for stable annual income but for a future exit at a higher valuation, which means growth through acquisition becomes the core strategy rather than an occasional opportunity.
This dynamic is familiar across healthcare services. Similar consolidation patterns have reshaped dental practices, dermatology groups, physical therapy networks, and behavioral health providers over the past fifteen years. Eye care arrived at this inflection point later than some sectors, partly because optometry has traditionally been organized around independent owner-operators rather than large institutional groups. That structure is now eroding rapidly.
The economics that drive this consolidation are not mysterious. A network of three hundred locations can negotiate insurance reimbursement rates that a single practice cannot. Centralized purchasing of frames, contact lenses, and equipment generates cost advantages that flow directly to margin. Back-office functions like billing, credentialing, and human resources – which consume significant time and money at the practice level – become shared costs spread across a much larger base. The financial logic of scale is real, and it makes the network more valuable than the sum of its parts.
Where private equity ownership creates tension is in the time horizon. Practices acquired in 2019 and 2020 are now approaching the point where the ownership group will seek a return. That typically means either a sale to a larger strategic buyer, a recapitalization, or a public offering. Each of those outcomes introduces new pressure on margins and operational decisions that can be difficult for employed optometrists and clinical staff to navigate. The doctors who sold their practices to gain freedom from business complexity sometimes find themselves operating inside a machine that has its own demands.
What This Means for Patients and Local Markets
For patients, the immediate experience of a MyEyeDr acquisition often feels unremarkable. The same front desk staff, the same exam rooms, the same doctor calling out prescription numbers. The differences emerge over time: standardized product assortments that may offer fewer boutique or independent frame brands, scheduling systems optimized for throughput, and clinical protocols that reflect corporate guidelines rather than individual physician judgment.
Independent optometrists who have not yet sold describe a market that grows harder to compete in as the network expands. When a major insurer signs a preferred-provider agreement with a large managed vision care operator, patients with that coverage face out-of-pocket costs at independent practices that they do not face inside the network. That structural disadvantage does not require any bad-faith behavior from anyone – it is simply what happens when a dominant buyer gains negotiating leverage over payers.
The Road Ahead for Holdouts
Not every independent optometrist is ready to sell, and not every regional group sees joining a managed care network as the right outcome. Some practices are differentiating aggressively on service quality, specialty offerings like low vision care or pediatric optometry, or frame selections that a standardized network cannot match. A growing number of owner-operators are also exploring group purchasing cooperatives and shared services models that let them capture some of the scale benefits without surrendering ownership.
These strategies can work, but they require sustained effort in a market where the consolidator’s advantages compound over time. MyEyeDr and its competitors in managed vision care are not standing still while independents adapt. The company continues to pursue acquisitions, and regional groups that once considered themselves too large or too established to be acquisition targets are finding that size does not provide the insulation they assumed. This consolidation pattern across healthcare services – whether in medical billing or clinical care – tends to accelerate once it reaches a tipping point, and eye care may be approaching that threshold faster than most people in the industry expected.
The harder question sitting underneath all of this is what optometry looks like in fifteen years if the current trajectory continues. If independent ownership continues to shrink, the pipeline of doctors who enter the profession expecting to eventually own a practice narrows. Optometry schools produce graduates who orient toward employment, not entrepreneurship. The profession’s culture shifts. And the negotiating leverage that individual doctors once held – the ability to walk away from an insurer, to set their own hours, to build a practice around their own values – quietly disappears, not in any single dramatic moment, but one practice sale at a time.
